Mission Pharmacal Company:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Mission Pharmacal Company - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3320
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mission Pharmacal Company (Mission Pharmacal) develops, manufactures and markets prescription, over-the-counter and dietary supplement products. It offers products for conditions related to women’s health, urology, pediatrics, and dermatology, among others. It also offers contract manufacturing services. Mission Pharmacal manufactures and markets products in various forms such as powders, tablets, solutions, creams, lotions, gels and suspensions. It operates in the US and international markets through its distribution and sales network. The company has a manufacturing facility in Texas, with capabilities such as warehousing, manufacturing, and research and development. Mission Pharmacal is headquartered in San Antonio, Texas, the US.

Mission Pharmacal Company – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mission Pharmacal Company, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Mission Pharmacal Company, Medical Devices Deals, 2012 to YTD 2018 9
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Espada Dermatology Acquires GlyDerm from Lautus Pharma 11
Mission Pharmacal Acquires Eletone Cream From Ferndale Healthcare 12
Partnerships 13
Otonomy Enters into Co-Promotion Agreement with Mission Pharmacal 13
Fabre-Kramer Pharma Enters into Agreement with Mission Pharmacal 14
DARA BioSciences Enters into Co-Promotion Agreement with Mission Pharmacal 15
Meda Enters Promotion Agreement With Mission Pharmacal For Elestrin 16
Licensing Agreements 17
MainPointe Pharma Enters into Licensing Agreement with Mission Pharmacal 17
Retrophin Amends Licensing Agreement with Mission Pharmacal for Thiola 18
EffRx Pharma Enters Into Licensing Agreement With Mission Pharmacal For Binosto 19
Asset Transactions 20
MainPointe Pharma Acquires Consumer Products from Mission Pharmacal 20
Acquisition 21
Mission Pharmacal Acquires ProSolus Pharma 21
Mission Pharmacal Company – Key Competitors 22
Mission Pharmacal Company – Key Employees 23
Mission Pharmacal Company – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Key Facts 2
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mission Pharmacal Company, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mission Pharmacal Company, Deals By Therapy Area, 2012 to YTD 2018 8
Mission Pharmacal Company, Medical Devices Deals, 2012 to YTD 2018 9
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Espada Dermatology Acquires GlyDerm from Lautus Pharma 11
Mission Pharmacal Acquires Eletone Cream From Ferndale Healthcare 12
Otonomy Enters into Co-Promotion Agreement with Mission Pharmacal 13
Fabre-Kramer Pharma Enters into Agreement with Mission Pharmacal 14
DARA BioSciences Enters into Co-Promotion Agreement with Mission Pharmacal 15
Meda Enters Promotion Agreement With Mission Pharmacal For Elestrin 16
MainPointe Pharma Enters into Licensing Agreement with Mission Pharmacal 17
Retrophin Amends Licensing Agreement with Mission Pharmacal for Thiola 18
EffRx Pharma Enters Into Licensing Agreement With Mission Pharmacal For Binosto 19
MainPointe Pharma Acquires Consumer Products from Mission Pharmacal 20
Mission Pharmacal Acquires ProSolus Pharma 21
Mission Pharmacal Company, Key Competitors 22
Mission Pharmacal Company, Key Employees 23
Mission Pharmacal Company, Other Locations 24
Mission Pharmacal Company, Subsidiaries 24

List of Figures
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mission Pharmacal Company, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Mission Pharmacal Company, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Mission Pharmacal Company:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sinclair Oil Corporation:企業の戦略・SWOT・財務分析
    Sinclair Oil Corporation - Strategy, SWOT and Corporate Finance Report Summary Sinclair Oil Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • California Resources Corp (CRC):企業の財務・戦略的SWOT分析
    California Resources Corp (CRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Nitto Denko Corp (6988):企業の財務・戦略的SWOT分析
    Nitto Denko Corp (6988) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Ternium SA:企業の戦略・SWOT・財務情報
    Ternium SA - Strategy, SWOT and Corporate Finance Report Summary Ternium SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Unity Biotechnology Inc (UBX):製薬・医療:M&Aディール及び事業提携情報
    Summary Unity Biotechnology Inc (Unity Biotechnology), formerly Forge Inc is a biotechnology company that researches, develops and commercializes therapeutics for the treatment of age-related diseases. The company focuses on the development of senolytic medicines to eliminate senescent cells. The co …
  • Rath AG:企業の戦略・SWOT・財務情報
    Rath AG - Strategy, SWOT and Corporate Finance Report Summary Rath AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Alitair Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Alitair Pharmaceuticals Inc (Alitair) is a pharmaceutical company that provides orphan drugs and medicine products. The company provides orphan drug products and RX and OTC cough and cold products. It offers orphan drug products such as ALT and oral drugs that are widely used to treat variou …
  • DIC Corp (4631):企業の財務・戦略的SWOT分析
    DIC Corp (4631) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Aareal Bank AG:企業の戦略・SWOT・財務情報
    Aareal Bank AG - Strategy, SWOT and Corporate Finance Report Summary Aareal Bank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Apollo Education Group, Inc.:企業の戦略・SWOT・財務分析
    Apollo Education Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Apollo Education Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Ebara Corp (6361):企業の財務・戦略的SWOT分析
    Ebara Corp (6361) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • IOI Corporation Berhad:企業の戦略・SWOT・財務分析
    IOI Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary IOI Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Luxfer Holdings PLC (LXFR):企業の財務・戦略的SWOT分析
    Luxfer Holdings PLC (LXFR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • DiaGenic ASA (NEL)-製薬・医療分野:企業M&A・提携分析
    Summary DiaGenic ASA (DiaGenic) is a medical device company that develops innovative in vitro diagnostic products for early detection of diseases. The company specializes in developing blood-based biomarkers. Its ADtect product is a blood test that helps distinguish mild to moderate range AD from th …
  • TransForce Inc.:企業のM&A・事業提携・投資動向
    TransForce Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's TransForce Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • UGE International Ltd (UGE):電力:M&Aディール及び事業提携情報
    Summary UGE International Ltd (UGE), formerly Way Ventures Inc, is a renewable energy company that operates through wind, solar, solar-wind technologies. The company’s products include electronics and accessories, wind turbines, solar panels, energy storage systems, mounting system, electronics, and …
  • The Chugoku Electric Power Co., Inc.:企業の戦略・SWOT・財務分析
    The Chugoku Electric Power Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary The Chugoku Electric Power Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • McWane Inc:企業の戦略的SWOT分析
    McWane Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Mahagenco:企業の戦略的SWOT分析
    Mahagenco - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Shangri-La Asia Ltd:戦略・SWOT・企業財務分析
    Shangri-La Asia Ltd - Strategy, SWOT and Corporate Finance Report Summary Shangri-La Asia Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆